论文信息 - A randomized phase II study of ipilimumab at 3 (ipi3) or 10 mg/kg (ipi10) alone or in combination with high dose interferon-alfa (HDI) in advanced melanoma (E3611). - 字舞流文

A randomized phase II study of ipilimumab at 3 (ipi3) or 10 mg/kg (ipi10) alone or in combination with high dose interferon-alfa (HDI) in advanced melanoma (E3611).

J. Kirkwood | M. Albertini | U. Rao | R. Conry | A. Tarhini | Sandra J. Lee | N. Laudi | Stuart J. Wong | Mark Taylor | P. Truong | A. Nagarajan | Jerry W. Mitchell